SEC Form 4 · accession 0001013606-15-000076
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Wilder
Director
Period of report
May 26, 2015
Accepted (ET)
May 27, 2015 · 12:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 26, 2015 | S | 3,790 | $16.08 | D | 14,553 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.10. The Reporting Person undertakes to provide Endologix, Inc., any security holder of Endologix, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each price within the ranges set forth in this Form 4.